or
forgot password
  • cancer clinical trials in columbus, OH

  • Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Doctors Hospital at Ohio Health

    Trial Locations
    Doctors Hospital at Ohio Health
    Riverside Methodist Hospital Cancer Care
    Mount Carmel Health - West Hospital
    Grant Medical Center Cancer Care
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
    Riverside Methodist Hospital Cancer Care

    Trial Locations
    Riverside Methodist Hospital Cancer Care
    Mount Carmel Health - West Hospital
    Grant Medical Center Cancer Care
    Breast Cancer
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Doctors Hospital

    Trial Locations
    Doctors Hospital
    Grant Medical Center
    Mount Carmel Health Center West
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
    Doctors Hospital

    Trial Locations
    Doctors Hospital
    Grant Medical Center
    Mount Carmel Health Center West
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    The Active After Cancer Trial (AACT)
    Ohio State University
    Columbus, Ohio 43210
    Breast Cancer, Colorectal Cancer
    Selumetinib in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

    Trial Locations
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
    Riverside Methodist Hospital
    Mount Carmel Health Center West
    Borderline Ovarian Surface Epithelial-stromal Tumor, Ovarian Serous Cystadenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Borderline Ovarian Surface Epithelial-stromal Tumor
    Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
    Doctors Hospital at Ohio Health

    Trial Locations
    Doctors Hospital at Ohio Health
    Riverside Methodist Hospital Cancer Care
    Mount Carmel Health - West Hospital
    Grant Medical Center Cancer Care
    Brain and Central Nervous System Tumors
    Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
    Columbus, Ohio 43210-1240
    Lymphoma
    Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
    Columbus, Ohio 43210-1240
    Recurrent Mantle Cell Lymphoma
    Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma
    Ohio State University Medical Center
    Columbus, Ohio 43210
    Lymphoma, Small Intestine Cancer
    Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

    Trial Locations
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
    Ohio State University Medical Center
    Recurrent Skin Cancer, Squamous Cell Carcinoma of the Skin, Stage 0 Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia
    Ph 2 Intensification Regimen for Previously Untreated, Resectable, Advanced Squamous Cell Cancer
    Ohio State University Medical Center
    Columbus, Ohio 43210
    Head and Neck Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
    Columbus, Ohio 43210-1240
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
    CCOP - Columbus

    Trial Locations
    CCOP - Columbus
    Doctors Hospital at Ohio Health
    Riverside Methodist Hospital Cancer Care
    Mount Carmel Health - West Hospital
    Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
    Grant Medical Center Cancer Care
    Prostate Cancer
    Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
    Columbus CCOP

    Trial Locations
    Columbus CCOP
    Doctors Hospital
    Grant Medical Center
    Mount Carmel Health Center West
    The Mark H Zangmeister Center
    Neuroendocrine Carcinoma
    AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Mount Carmel Health - West Hospital
    Columbus, Ohio 43222
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

    Trial Locations
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
    Riverside Methodist Hospital
    Columbus CCOP
    Doctors Hospital
    Grant Medical Center
    Mount Carmel Health Center West
    The Mark H Zangmeister Center
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

    Trial Locations
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
    Riverside Methodist Hospital
    Columbus CCOP
    Doctors Hospital
    Grant Medical Center
    Mount Carmel Health Center West
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer